Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.
Habitat for Humanity Building in Thorold
Police Target Trucks By-Passing Inspection
Bob Cole Dies at the Age of 90
Suspect Sought After Cannabis Store Robbery
Niagara Transit to Receive Gas Tax Money
Local Power Company Upgrading Technology
Police Called Concerning Armed Individual
Man Arrested in Connection to School Threats